Is it unsafe for a patient with hypertension to be prescribed two PDE‑5 inhibitors—Cialis (tadalafil) and daily tadalafil—concurrently?

This is a Dangerous Prescribing Error That Must Be Corrected Immediately

The patient should NOT be taking two separate prescriptions of the same PDE5 inhibitor (Cialis and daily tadalafil are the same drug), as this represents inappropriate duplicate therapy that significantly increases the risk of serious adverse events including severe hypotension, priapism, and other dose-dependent side effects. 1

Why This is Dangerous

Duplicate Therapy Problem

• Cialis IS tadalafil - these are not two different medications
• The patient is essentially taking a double dose of the same drug
• This creates excessive PDE5 inhibition with cumulative vasodilatory effects

Specific Safety Concerns

Hypotension Risk:

• PDE5 inhibitors are mild vasodilators that lower blood pressure 2, 1
• Excessive dosing amplifies blood pressure lowering effects
• In hypertensive patients, this can cause symptomatic hypotension, dizziness, syncope, and falls
• Risk is particularly high if the patient is also taking antihypertensives, alpha-blockers, or (critically dangerous) nitrates 1, 3

Dose-Dependent Adverse Events: The FDA label explicitly warns that combining PDE5 inhibitors has not been studied for safety 1. Common adverse effects that worsen with higher doses include:

• Headache (increases from 5% to 15% with higher doses)
• Dyspepsia (1% to 10%)
• Back pain and myalgia
• Visual disturbances
• Flushing and nasal congestion 1

Serious Rare Events:

• Priapism (prolonged painful erection requiring emergency intervention)
• NAION (sudden vision loss) - risk may increase with higher exposure 4
• Severe hypotension requiring hospitalization

Immediate Action Required

The prescribing clinician must:

1. Discontinue one prescription immediately - the patient should only take ONE tadalafil formulation

2. Clarify the intended regimen:

   • For erectile dysfunction: Either as-needed dosing (10-20 mg before sexual activity) OR daily dosing (2.5-5 mg once daily) - never both 1
   • For BPH/ED combination: Daily dosing only (5 mg once daily) 1

3. Review all current medications to check for dangerous interactions:

   • Absolute contraindication: Any nitrate use (nitroglycerin, isosorbide) 4, 1
   • Caution required: Alpha-blockers (except tamsulosin), multiple antihypertensives 1, 3
   • Dose adjustment needed: CYP3A4 inhibitors (ketoconazole, ritonavir, erythromycin) 1

4. Assess for signs of overdose:

   • Symptomatic hypotension or orthostasis
   • Severe headache or visual changes
   • Prolonged erection (>4 hours requires emergency care)

The Correct Approach

FDA-approved dosing for tadalafil 1:

• ED (as needed): 10 mg before sexual activity (range 5-20 mg), maximum once per 24 hours
• ED (daily): 2.5-5 mg once daily
• BPH or ED/BPH: 5 mg once daily

Never combine:

• Different PDE5 inhibitors together
• As-needed and daily dosing of the same PDE5 inhibitor
• PDE5 inhibitors with nitrates (absolute contraindication)

Critical Pitfall to Avoid

The FDA label explicitly states: "The safety and efficacy of combinations of CIALIS and other PDE5 inhibitors or treatments for erectile dysfunction have not been studied. Inform patients not to take CIALIS with other PDE5 inhibitors, including ADCIRCA." 1

This warning applies equally to combining the same PDE5 inhibitor with itself through duplicate prescriptions. This represents a medication error that requires immediate correction to prevent potentially serious harm to the patient.